Ainos (AIMD) Stock Price

Ainos Price

NYSE·CLOSED
1.25
​
Market closed

Revenue at Ainos has contracted by 0.4% per year over the past 19 years to 124,157.00 USD. For Ainos, the net margin of -11,897.0% is down versus -654.0% a few years ago.

Ainos stock price

Access this data via the Eulerpool API

Ainos business model & stock analysis

Ainos Inc is a US-based company operating in Biotechnology industry. The company is headquartered in San Diego, California and currently employs 43 full-time employees. Ainos, Inc. is engaged in developing medical technologies for point-of-care (POCT) testing and medical treatment for a range of disease indications. The firm is engaged in the research and clinical development activities for its programs, securing related intellectual property, and commercializing therapeutics using low-dose non-injectable interferon (IFN). Its Medtech solutions includes COVID-19 Antigen Rapid Test Kit, Volatile Organic Compounds (VOC) POCT-Ainos Flora, VOC POCT-Ainos Pen, VOC POCT-CHS430, Very Low-Dose Oral Interferon Alpha (VELDONA) and Synthetic RNA (SRNA). Its Ainos Flora device is intended to perform a non-invasive test for female vaginal health and certain common sexually transmitted diseases (STDs). Ainos Pen device is a cloud-connected, multi-purpose, portable breath analyzer that is intended to monitor health conditions. The CHS430 device is intended to provide non-invasive testing for ventilator-associated pneumonia.

Frequently asked questions about Ainos

Converted at the current exchange rate, the Ainos share trades at 1.12 EUR (1.25 USD).

The revenue cannot currently be calculated for Ainos.

The profit cannot currently be calculated for Ainos.

The P/E ratio cannot be calculated for Ainos at the moment.

The P/S cannot be calculated for Ainos currently.

The Eulerpool Quality Score for Ainos is 3/10.

The ISIN of Ainos is US00902F4028. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Ainos is AIMD. The ticker symbol is used to trade Ainos shares on the stock exchange.

Fair ValueTerminal
1.08 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
2,887.37 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website ainos.com
Currency
USD
Initial public offering
Aug 8, 1996
ISIN
US00902F4028
Cusip
00902F303
Market capitalization
8.73 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
1.15
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-79.57 %
Last updated Oct 11, 2026, 3:15 PM

Ainos Peer Group

All fundamentals and in-depth analysis of Ainos

Our stock analysis for Ainos stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ainos. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.